Carregant...
Hyperphosphatemia Management in Patients with Chronic Kidney Disease
Hyperphosphatemia in chronic kidney disease (CKD) patients is a potentially life altering condition that can lead to cardiovascular calcification, metabolic bone disease (renal osteodystrophy) and the development of secondary hyperparathyroidism (SHPT). It is also associated with increased prevalenc...
Guardat en:
| Publicat a: | Saudi Pharm J |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4908098/ https://ncbi.nlm.nih.gov/pubmed/27330380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsps.2015.01.009 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|